On the third attempt, the FDA approved the treatment for generalized hypoactive sexual desire disorder in premenopausal women.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content